ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2501

Microvascular dysfunction contributes to hand bone deterioration in SSc patients

Rosanna Campitiello1, Sabrina Paolino2, Andrea Casabella3, Giulia Davoli2, Elisa Caratto4, Emanuele Gotelli1, Elvis Hysa5, Carmen Pizzorni2, Vanessa Smith6, Alberto Sulli2 and Maurizio Cutolo7, 1University of Genoa, Genoa, Liguria, Italy, 2University of Genoa, Genova, Italy, 3IRCCS Ospedale Policlinico San Martino, Genova, Italy, 4Univeristy of Genoa, Alessandria, Italy, 5University of Genoa, Genoa, Italy, 6Ghent University Hospital, Gent, Belgium, 7University of Genova, Genova, Italy

Meeting: ACR Convergence 2025

Keywords: body composition, Bone density, Dual energy x-ray absorptiometry (DEXA), osteoporosis, Systemic sclerosis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 28, 2025

Title: (2470–2503) Systemic Sclerosis & Related Disorders – Clinical Poster III

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: Systemic sclerosis (SSc) is a rare autoimmune disease characterized by endothelial dysfunction, self-reactive immune response and progressive systemic fibrosis1. It is well established that bone micro- and macroarchitectural damage is more prevalent in patients (pts) with SSc compared to healthy subjects(HS)2. Moreover, in SSc pts severe microvascular damage exhibit significant alterations in bone health, indicating a strong connection between microvascular dysfunction and muscle/bone impairment3. Consequently, the impaired peripheral microcirculation may contribute to the development of localized hand osteoporosis in SSc. The aim of this study was to assess the hand bone quality in SSc pts in correlation with peripheral microcirculatory status assessed with NVC analysis.

Methods: Hand (left and right) and total BMD and BMC were assessed by DXA and a dedicated software (GE Lunar, USA) in 32 SSc pts (age 61 ± 14 years, 94% women) affected by limited or diffuse cutaneous (dcSSc 47%) according to the 2013 EULAR/ACR criteria and 30 age-matched HS. Progressive peripheral microvascular damage, assessed by validates nailfold capillaroscopy (NVC)4. Statistical analysis was carried out by non-parametric tests and logistic regression analysis was performed to examine the influence of the capillary loss and hand bone status.

Results: Data revealed significantly lower hand BMD and BMC values (mean±SD) in SSc pts and age matched HS (BMD 0.31 ± 0.07vs 0.39 ± 0.06, p < 0.01; BMC 21.27±7.32 vs 30.09 ± 7.8, p< 0,01). The presence of SSc was associated with lower hand BMD compared with HS (adjusted for age, gender, BMI and history of osteoporosis; Beta= -0.2234, p = 0.025). In SSc pts a positive correlation was observed between hand and both spine vertebral bodies values (r(30) = 0.4671, p = 0.007) and femoral bone status (Neck r(30) = 0.3866, p = 0.029; total r(30) = 0,354, p = 0,047). Clinical, laboratory and NVC correlations have been performed (Table I). The regression analysis revealed that reduced capillary count significantly accounted for 38.26% of the variance in BMD values (R² = 0.3826, F = 17.35, p < 0.001).

Conclusion: In conclusion, hand bone status in SSc pts was found significantly lower compared to spine and femor bone and HC as well as associated with disease severity. The hand bone damage seems linked to the microvascular insufficiency. Therefore, care to the bone status should be taken as consequence of the progressive microvasculatory damage/insufficiency in SSc.References: 1) Volkmann, E. R. et al. (2023). Systemic sclerosis. The Lancet, 401(10371), 304–318. 2) Omair, M. A. et al. (2013). Low bone density in systemic sclerosis: A systematic review. The Journal of Rheumatology, 40(11), 1881–1890. 3) Paolino, S. et al. (2021). Body composition and bone status in relation to microvascular damage in systemic sclerosis patients. Journal of Endocrinological Investigation, 44(2), 255–264. 4) Smith, V. et al. (2020). Standardisation of nailfold capillaroscopy for the assessment of patients with Raynaud’s phenomenon and systemic sclerosis. Autoimmunity Reviews, 19(3), 102458.

Supporting image 1Table I. Statistically significant Spearman correlations between hand BMD and BMC and clinical features, antibody profiles, and NVC parameters in SSc patients.

Abbreviations: BMD: bone mineral density; BMC: bone mineral content; SSc: systemic sclerosis; GI: gastrointestinal involvement; mRSS: modified Rodnan skin score; NVC: nailfold videocapillaroscopy; ACA: anticentromere antibodies; SCL70: anti-topoisomerase I antibodies.


Disclosures: R. Campitiello: None; S. Paolino: None; A. Casabella: None; G. Davoli: None; E. Caratto: None; E. Gotelli: None; E. Hysa: None; C. Pizzorni: None; V. Smith: Argenx, 2, Boehringer-Ingelheim, 2, 5, 6, GlaxoSmithKlein(GSK), 2, Janssen, 2, 5, 6; A. Sulli: None; M. Cutolo: None.

To cite this abstract in AMA style:

Campitiello R, Paolino S, Casabella A, Davoli G, Caratto E, Gotelli E, Hysa E, Pizzorni C, Smith V, Sulli A, Cutolo M. Microvascular dysfunction contributes to hand bone deterioration in SSc patients [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/microvascular-dysfunction-contributes-to-hand-bone-deterioration-in-ssc-patients/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/microvascular-dysfunction-contributes-to-hand-bone-deterioration-in-ssc-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology